ScreenerHero

RMTI Rockwell Medical, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · rockwellmed.com
8.020USD-2.43%Mkt Cap: 32.32M $P/E: —

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap32.32M USD
Enterprise Value19.97M USD
Revenue (TTM)69.39M USD
Gross Profit11.70M USD
Net Income (TTM)-5.31M USD
Revenue/Share17.97 USD
Last Price8.020 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees157
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)109.29
PEG4.43
EV/EBITDA-8.22
EV/Revenue0.29
P/S0.44
P/B0.87
EPS (TTM)-1.22
EPS (Forward)0.07
52W Range
4.88539% of range12.90
52W High12.90 USD
52W Low4.885 USD
Profitability
Gross Margin16.89%
Oper. Margin-5.97%
EBITDA Margin-3.50%
Profit Margin-7.67%
ROE-14.37%
ROA-9.30%
Growth
Revenue Growth10.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-659.00K USD
CapEx (TTM)542.00K USD
FCF Margin0.50%
FCF Yield1.08%
Net Debt-10.86M USD
Net Debt/EBITDA4.47
Balance Sheet
Debt/Equity0.34
Current Ratio3.25
Quick Ratio2.96
Book Value/Sh8.83 USD
Cash/Share6.15 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 1, 2026
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+149.4%
Target Range20.00 USD – 20.00 USD
# Analysts2
Ownership
Shares Out.4.03M
Float3.58M
Insiders14.80%
Institutions8.52%
Short Interest
Short Ratio3.8d
Short % Float2.28%
Short % Out.2.23%
Shares Short89.87K
Short (prev mo.)88.03K
Technical
SMA 507.860 (+2.0%)
SMA 2008.368 (-4.2%)
Beta1.63
S&P 52W Chg16.45%
Avg Vol (30d)21.96K
Avg Vol (10d)18.28K
Technical Indicators
RSI (14)48.8
MACD0.1335
MACD Signal0.2315
MACD Hist.-0.0980
BB Upper8.969 USD
BB Middle8.261 USD
BB Lower7.553 USD
BB Width17.14%
ATR (14)0.4466 USD
Vol Ratio (20d)0.36x